vs
Cricut, Inc.（CRCT）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
Cricut, Inc.的季度营收约是REPLIGEN CORP的1.0倍（$203.6M vs $197.9M），REPLIGEN CORP净利率更高（6.7% vs 3.8%，领先2.9%），REPLIGEN CORP同比增速更快（13.6% vs -2.7%），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 10.3%）
Cricut, Inc.是面向家庭手工爱好者的美国品牌，主营计算机控制的切割机产品。这类设备可切割纸张、毛毡、乙烯基、布料，也可加工皮革、纸板、木材等多种材料，是手工创作场景的实用工具。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
CRCT vs RGEN — 直观对比
营收规模更大
CRCT
是对方的1.0倍
$197.9M
营收增速更快
RGEN
高出16.4%
-2.7%
净利率更高
RGEN
高出2.9%
3.8%
两年增速更快
RGEN
近两年复合增速
10.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $203.6M | $197.9M |
| 净利润 | $7.8M | $13.3M |
| 毛利率 | 47.4% | 52.5% |
| 营业利润率 | 6.8% | 9.0% |
| 净利率 | 3.8% | 6.7% |
| 营收同比 | -2.7% | 13.6% |
| 净利润同比 | -34.7% | 143.9% |
| 每股收益（稀释后） | $0.03 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CRCTRGEN
| Q4 25 | $203.6M | $197.9M | ||
| Q3 25 | $170.4M | $188.8M | ||
| Q2 25 | $172.1M | $182.4M | ||
| Q1 25 | $162.6M | $169.2M | ||
| Q4 24 | $209.3M | $174.1M | ||
| Q3 24 | $167.9M | $154.9M | ||
| Q2 24 | $167.9M | $154.1M | ||
| Q1 24 | $167.4M | $151.3M |
净利润CRCTRGEN
| Q4 25 | $7.8M | $13.3M | ||
| Q3 25 | $20.5M | $14.9M | ||
| Q2 25 | $24.5M | $14.9M | ||
| Q1 25 | $23.9M | $5.8M | ||
| Q4 24 | $11.9M | $-30.3M | ||
| Q3 24 | $11.5M | $-654.0K | ||
| Q2 24 | $19.8M | $3.3M | ||
| Q1 24 | $19.6M | $2.1M |
毛利率CRCTRGEN
| Q4 25 | 47.4% | 52.5% | ||
| Q3 25 | 55.2% | 53.2% | ||
| Q2 25 | 59.0% | 50.0% | ||
| Q1 25 | 60.5% | 53.6% | ||
| Q4 24 | 44.9% | 26.1% | ||
| Q3 24 | 46.1% | 50.0% | ||
| Q2 24 | 53.5% | 49.8% | ||
| Q1 24 | 54.7% | 49.5% |
营业利润率CRCTRGEN
| Q4 25 | 6.8% | 9.0% | ||
| Q3 25 | 13.3% | 8.9% | ||
| Q2 25 | 17.5% | 7.6% | ||
| Q1 25 | 18.0% | 3.9% | ||
| Q4 24 | 6.6% | -17.7% | ||
| Q3 24 | 6.3% | -5.1% | ||
| Q2 24 | 15.7% | 1.0% | ||
| Q1 24 | 15.1% | 1.3% |
净利率CRCTRGEN
| Q4 25 | 3.8% | 6.7% | ||
| Q3 25 | 12.0% | 7.9% | ||
| Q2 25 | 14.2% | 8.2% | ||
| Q1 25 | 14.7% | 3.4% | ||
| Q4 24 | 5.7% | -17.4% | ||
| Q3 24 | 6.8% | -0.4% | ||
| Q2 24 | 11.8% | 2.2% | ||
| Q1 24 | 11.7% | 1.4% |
每股收益（稀释后）CRCTRGEN
| Q4 25 | $0.03 | $0.24 | ||
| Q3 25 | $0.10 | $0.26 | ||
| Q2 25 | $0.11 | $0.26 | ||
| Q1 25 | $0.11 | $0.10 | ||
| Q4 24 | $0.06 | $-0.55 | ||
| Q3 24 | $0.05 | $-0.01 | ||
| Q2 24 | $0.09 | $0.06 | ||
| Q1 24 | $0.09 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $275.6M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $343.6M | $2.1B |
| 总资产 | $580.8M | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资CRCTRGEN
| Q4 25 | $275.6M | $767.6M | ||
| Q3 25 | $207.1M | $748.7M | ||
| Q2 25 | $376.9M | $708.9M | ||
| Q1 25 | $356.7M | $697.2M | ||
| Q4 24 | $336.9M | $757.4M | ||
| Q3 24 | $246.9M | $784.0M | ||
| Q2 24 | $299.5M | $809.1M | ||
| Q1 24 | $281.7M | $780.6M |
总债务CRCTRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益CRCTRGEN
| Q4 25 | $343.6M | $2.1B | ||
| Q3 25 | $358.4M | $2.1B | ||
| Q2 25 | $308.9M | $2.1B | ||
| Q1 25 | $490.2M | $2.0B | ||
| Q4 24 | $466.8M | $2.0B | ||
| Q3 24 | $475.8M | $2.0B | ||
| Q2 24 | $448.5M | $2.0B | ||
| Q1 24 | $552.6M | $2.0B |
总资产CRCTRGEN
| Q4 25 | $580.8M | $2.9B | ||
| Q3 25 | $564.3M | $2.9B | ||
| Q2 25 | $721.5M | $2.9B | ||
| Q1 25 | $681.7M | $2.9B | ||
| Q4 24 | $693.0M | $2.8B | ||
| Q3 24 | $663.8M | $2.8B | ||
| Q2 24 | $742.1M | $2.9B | ||
| Q1 24 | $723.7M | $2.8B |
负债/权益比CRCTRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $82.4M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | 10.58× | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流CRCTRGEN
| Q4 25 | $82.4M | $25.7M | ||
| Q3 25 | $20.5M | $48.1M | ||
| Q2 25 | $36.2M | $28.6M | ||
| Q1 25 | $61.2M | $15.0M | ||
| Q4 24 | $103.1M | $39.2M | ||
| Q3 24 | $70.2M | $49.3M | ||
| Q2 24 | $35.0M | $42.2M | ||
| Q1 24 | $56.7M | $44.7M |
自由现金流CRCTRGEN
| Q4 25 | — | $17.6M | ||
| Q3 25 | — | $43.4M | ||
| Q2 25 | — | $21.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $33.6M | ||
| Q3 24 | — | $42.3M | ||
| Q2 24 | — | $37.4M | ||
| Q1 24 | — | $36.4M |
自由现金流率CRCTRGEN
| Q4 25 | — | 8.9% | ||
| Q3 25 | — | 23.0% | ||
| Q2 25 | — | 11.8% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | — | 19.3% | ||
| Q3 24 | — | 27.3% | ||
| Q2 24 | — | 24.3% | ||
| Q1 24 | — | 24.0% |
资本支出强度CRCTRGEN
| Q4 25 | — | 4.1% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | — | 3.9% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | — | 5.5% |
现金转化率CRCTRGEN
| Q4 25 | 10.58× | 1.93× | ||
| Q3 25 | 1.00× | 3.23× | ||
| Q2 25 | 1.48× | 1.92× | ||
| Q1 25 | 2.56× | 2.57× | ||
| Q4 24 | 8.64× | — | ||
| Q3 24 | 6.11× | — | ||
| Q2 24 | 1.77× | 12.70× | ||
| Q1 24 | 2.89× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRCT
| Platform | $83.9M | 41% |
| Connected Machines | $65.2M | 32% |
| Accessories And Materials | $54.4M | 27% |
RGEN
暂无分部数据
